A “National Technology Adoption Hub” for healthcare has been unveiled in Manchester. The hub is aimed at helping the NHS better implement new cost-effective, life-saving technologies.
Hosted by the Central Manchester and Manchester Children’s University Hospital Trust, it will take up 15 innovative medical technologies over the next three years, and examine how they can be put into practice in the quickest, most effective way to improve NHS productivity. The Hub is supported by Professor Lord Ara Darzi, who is currently leading a review of the NHS:
Schemes such as the National Technology Adoption Hub shows the extent of the innovation and development within the NHS. It is encouraging to see the NHS continually striving to find the best standards of care, using the latest available techniques, for its patients.”
The three technologies to be reviewed in the first wave of the Hub project are: Deltex Medical’s CardioQ Oesophageal Doppler monitoring machine, the CT3000 Non-Invasive Bladder Analysis for Men manufactured by Mediplus and the 12 Lead ECG Telemedicine GP Programme developed by Broomwell Healthwatch. All three products are proven, cost-effective measures that have delivered real benefits to trusts and patients where implemented, and could transform the standards of care up and down the country.
Ewan Phillips, Managing Director of Deltex Medical, commented: “We are delighted that the CardioQ has been selected for the first wave of the new National Technology Adoption Hub. If rolled out across the NHS, we believe it could lead to savings of £500 million a year.”
